Citation Impact
Citing Papers
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
Gastrointestinal dysfunction in Parkinson's disease
2003 Standout
Functional Gastroduodenal Disorders
2006 Standout
Indocyanine Green Retention Test as a Noninvasive Marker of Portal Hypertension and Esophageal Varices in Compensated Liver Cirrhosis
2013
Emergence of Clarithromycin‐Resistant Helicobacter pylori (CRHP) with a High Prevalence in Children Compared with Their Parents
2002
Phenotypic and genotypic Helicobacter pylori clarithromycin resistance and therapeutic outcome: benefits and limits
2009
Clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics
2004
Dyspepsia and Health Care Seeking in a Community (How Important Are Psychological Factors?)
1998
Attempts to enhance the eradication rate ofHelicobacter pyloriinfection
2014
Alternative and rescue treatment regimens for Helicobacter pylori eradication
2002
Meta‐analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first‐line therapies for Helicobacter pylori
2007
Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis
2017 Standout
Measurement of Spleen Stiffness to Evaluate Portal Hypertension and the Presence of Esophageal Varices in Patients With HCV-Related Cirrhosis
2012
Portal Hypertension in Patients with Liver Cirrhosis: Diagnostic Accuracy of Spleen Stiffness
2015
ORAL MITEMCINAL (GM‐611), AN ERYTHROMYCIN‐DERIVED PROKINETIC, ACCELERATES NORMAL AND EXPERIMENTALLY DELAYED GASTRIC EMPTYING IN CONSCIOUS DOGS
2007 StandoutNobel
Portal hypertensive bleeding in cirrhosis
2016 Standout
Predominant Symptoms Identify Different Subgroups in Functional Dyspepsia
1999
The Functional Gastrointestinal Disorders and the Rome III Process
2006 Standout
Reassessment of the Diagnostic Value of Histology in Patients with GERD, Using Multiple Biopsy Sites and an Appropriate Control Group
2005
Role of antibiotic sensitivity testing before first‐line Helicobacter pylori eradication treatments
2003
Mechanisms of Hepatic Fibrogenesis
2008 Standout
Liver Volume as a Predictor of Functional Improvement Post-DAA Treatment
2017
Comparative study of Nigella Sativa and triple therapy in eradication of Helicobacter Pylori in patients with non-ulcer dyspepsia
2010
Spleen stiffness measurement can predict clinical complications in compensated HCV-related cirrhosis: A prospective study
2014
Management of Varices and Variceal Hemorrhage in Cirrhosis
2010
Acid Suppression and Chemoprevention in Barrett’s Oesophagus
2004
A Liver Stiffness Measurement-Based, Noninvasive Prediction Model for High-Risk Esophageal Varices in B-Viral Liver Cirrhosis
2010
MITEMCINAL (GM‐611), AN ORALLY ACTIVE MOTILIN RECEPTOR AGONIST, IMPROVES DELAYED GASTRIC EMPTYING IN A CANINE MODEL OF DIABETIC GASTROPARESIS
2008 StandoutNobel
Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions
2018 Standout
The Montreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based Consensus
2006 Standout
H pylori antibiotic resistance: prevalence, importance, and advances in testing
2004 Standout
Treatment of functional dyspepsia
2005
Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis
2013 Standout
Helicobacter pyloriInfection
2002 Standout
Photodynamic therapy: a new antimicrobial approach to infectious disease?
2004 Standout
Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices
2006
Influence of cure of Helicobacter pylori infection on gastric acidity and gastroesophageal reflux: study by 24-h pH monitoring in patients with gastric or duodenal ulcer
2005
Ranitidine Bismuth Citrate Can Help to Overcome Helicobacter pylori Resistance to Clarithromycin In Vivo
2000
Antimicrobial strategies centered around reactive oxygen species – bactericidal antibiotics, photodynamic therapy, and beyond
2013 Standout
Measurement of Spleen Stiffness by Acoustic Radiation Force Impulse Imaging Identifies Cirrhotic Patients With Esophageal Varices
2012
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report
2006 Standout
Photodynamic therapy for localized infections—State of the art
2009 Standout
A review on therapeutic potential of Nigella sativa: A miracle herb
2013 Standout
Elastography, Spleen Size, and Platelet Count Identify Portal Hypertension in Patients With Compensated Cirrhosis
2012
American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis
2004
Helicobacter pyloriDetection and Antimicrobial Susceptibility Testing
2007
Prevalence and Treatment ofHelicobacter pyloriin Patients with Blepharitis
2006
Helicobacter pylori eradication: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics for 1 week—a meta‐analysis of efficacy
2000
Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments
2010 Standout
Evaluation of two enzyme immunoassays for detecting Helicobacter pylori in stool specimens of dyspeptic patients after eradication therapy
2005
Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: The “Anticipate” study
2016
One‐week ranitidine bismuth citrate in combinations with metronidazole, amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection: the RBC‐MACH study
1999
The International Workshop on Meibomian Gland Dysfunction: Report of the Subcommittee on Management and Treatment of Meibomian Gland Dysfunction
2011 Standout
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Claritromycin resistance and Helicobacter pylori genotypes in Italy.
2006
Ultrasound Elastography: Review of Techniques and Clinical Applications
2017 Standout
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Works of M.R. Mele being referenced
Comparison of the main oesophageal pathophysiological characteristics between short‐ and long‐segment Barrett's oesophagus
2002
A new 1‐week therapy for Helicobacter pylori eradication: rani‐ tidine bismuth citrate plus two antibiotics
1997
Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis
2003
Stool antigen assay (HpSA) is less reliable than urea breath test for post‐treatment diagnosis of Helicobacter pylori infection
2002
Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis
2000
Optimal duration of therapy combining ranitidine bismuth citrate with clarithromycin and metronidazole in the eradication of Helicobacter pylori infection
1999
Are clinical patterns of dyspepsia a valid guideline for appropriate use of endoscopy? A report on 2253 dyspeptic patients.
1993
Histological and functional recovery in patients with multifocal atrophic gastritis after eradication of Helicobacter pylori infection.
1999
Head‐to‐head comparison of 1‐week triple regimens combining ranitidine or omeprazole with two antibiotics to eradicate Helicobacter pylori
1999
The impact of antibiotic resistance on the efficacy of three 7‐day regimens against Helicobacter pylori
2000